Global X China Biotech ETF (HKG:2820)
77.88
-2.10 (-2.63%)
Sep 26, 2025, 4:08 PM HKT
HKG:2820 Holdings Information
HKG:2820 is an equity ETF with a total of 30 individual holdings. The top holdings are WuXi Biologics stock at 10.93%, WuXi AppTec at 10.09%, BeOne Medicines AG at 9.51%, Jiangsu Hengrui Medicine at 9.24%, and Innovent Biologics at 8.60%.
Total Holdings
30
Top 10 Percentage
69.46%
Asset Class
Equity
ETF Category
Health Care
Assets
650.92M
PE Ratio
39.60
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 10.93% |
2 | SHA: 603259 | WuXi AppTec Co., Ltd. | 10.09% |
3 | ONC | BeOne Medicines AG | 9.51% |
4 | SHA: 600276 | Jiangsu Hengrui Medicine Co., Ltd. | 9.24% |
5 | HKG: 1801 | Innovent Biologics, Inc. | 8.60% |
6 | HKG: 9926 | Akeso, Inc. | 5.85% |
7 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.67% |
8 | HKG: 1530 | 3SBio Inc. | 3.96% |
9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.00% |
10 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 2.63% |
11 | SHA: 688331 | RemeGen Co., Ltd. | 2.52% |
12 | ZLAB | Zai Lab Limited | 2.34% |
13 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 2.22% |
14 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 1.99% |
15 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.96% |
16 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 1.78% |
17 | SHE: 300255 | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 1.74% |
18 | SHA: 688114 | MGI Tech Co., Ltd. | 1.61% |
19 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 1.51% |
20 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 1.45% |
21 | HKG: 1548 | Genscript Biotech Corporation | 1.44% |
22 | HKG: 0867 | China Medical System Holdings Limited | 1.39% |
23 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.34% |
24 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 1.30% |
25 | SHE: 002007 | Hualan Biological Engineering Inc. | 1.26% |
As of Sep 25, 2025